Adaptive Biotechnologies Corporation (ADPT) Deep Dive Video
Summary
Adaptive Biotechnologies is turning clonoSEQ into a scalable, high‑margin MRD diagnostics engine—racing toward profitability while competition and reimbursement remain the swing factors.